Arcus Biosciences, Inc.RCUSNYSE
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-335.00M
↓ 137% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-141.40M
Historical baseline
PeriodValueYoY Change
2025$-335.00M-24.5%
2024$-269.00M+7.6%
2023$-291.00M-12.8%
2022$-258.00M-537.3%
2021$59.00M+149.2%
2020$-120.00M-47.9%
2019$-81.13M-58.5%
2018$-51.20M-0.7%
2017$-50.83M-201.3%
2016$-16.87M-